Canaan has put together an $800 million investment fund. The fund positions Canaan to place a fresh round of bets on early-stage biotechs, continuing the strategy that has delivered it paydays as companies including Johnson & Johnson and Teva have snapped up pieces of its portfolio.
{iframe}http://www.fiercebiotech.com/biotech/canaan-unveils-800m-fund-for-fresh-wave-biotech-bets{/iframe}